Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fauna Partnership
Emeryville, California, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Fauna Bio’s platform has resulted in multiple, pharma-partnered target identification programs; its collaboration with Eli Lilly on obesity research confirms strong pharma validation but no disclosed clinical-stage assets as of mid-2025.
- Therapeutic areas
- EndocrinologyMetabolic DisordersRheumatologyRare DiseasesCardiovascularNeurology
- Modalities
- Small moleculeProteinAntibodyPeptideOthers
- Industry
- Drug Discovery Services
02
Partnerships
Eli Lilly (strategic partnership for obesity targets)Zoonomia Consortium (comparative genomics collaboration)NASA (space biology programs)
Beyond the preview
Go deeper on Fauna Partnership.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Fauna Partnership.